Cargando…
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors
High-grade serous ovarian cancer (HGSOC) is an aggressive disease that typically develops drug resistance, thus novel biomarker-driven strategies are required. Targeted therapy focuses on synthetic lethality—pioneered by PARP inhibition of BRCA1/2-mutant disease. Subsequently, targeting the DNA repl...
Autores principales: | Golder, Anya, Nelson, Louisa, Tighe, Anthony, Barnes, Bethany, Coulson-Gilmer, Camilla, Morgan, Robert D, McGrail, Joanne C, Taylor, Stephen S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653014/ https://www.ncbi.nlm.nih.gov/pubmed/36381271 http://dx.doi.org/10.1093/narcan/zcac036 |
Ejemplares similares
-
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
por: Dibitetto, Diego, et al.
Publicado: (2020) -
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe
por: Heyza, Joshua R, et al.
Publicado: (2023) -
SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma
por: Kurashima, Kiminori, et al.
Publicado: (2020) -
Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low-dose treatment of high-grade serous ovarian carcinoma
por: Benada, Jan, et al.
Publicado: (2023) -
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
por: Armstrong, Chris W D, et al.
Publicado: (2020)